🔥 We have been featured on Shark Tank India.Episode 13

🔥 We have been featured on Shark Tank India

logologo
Search anything
Ctrl+K
gift
arrow
WhatsApp Icon

Stock Summary and Key Metrics













Investment Checklist




























Forecasts

No ConstituentsNo Constituents

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Ask AI

mockupmockup

Consolidated Half Yearly Results (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2025Sep 2025
Sales5865
Expenses5257
Interest1.431.95
Operating Profit5.457.66
OPM %9.4311.85
Other Income2.712.33
Depreciation0.740.74
Profit Before Tax5.997.30
Tax %18.8625.21
Net Profit4.865.46
EPS in Rs

Consolidated Profit Loss (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2025
Sales107
Expenses98
Operating Profit8.98
OPM %8.42
Other Income5.12
Interest2.20
Depreciation1.43
Profit Before Tax10
Tax %23.17
Net Profit8.04
EPS in Rs
Dividend Payout %0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2025
Equity Capital10
Reserves53
Borrowings31
Other Liabilities54
Total Liabilities148
Fixed Assets40
CWIP12
Investments1.25
Other Assets95
Total Assets148

Consolidated Cash Flows (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2025
Cash from Operating Activity8.84
Cash from Investing Activity-30
Cash from Financing Activity18
Net Cash Flow-3.79

Shareholdings

Shareholding History

Quarterly
Yearly
Quarterly
Jun 2023Sep 2023Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025
Promoters73.56%73.56%73.56%73.56%73.56%58.90%58.90%
FIIs2.41%0.03%0.00%0.00%0.39%0.15%0.15%
DIIs6.99%4.26%1.97%1.13%1.11%10.80%10.80%
Public17.04%22.15%24.47%25.30%24.93%30.14%30.14%
Total Shareholders8307221,2291,2481,229748758

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

professionalIcon

Upgrade

transaction-premiumtransaction-premium

Projection

No ConstituentsNo Constituents

Documents

Presentations
Concalls
Reports
Presentations

No documents found!

Actions

Action Type




























































AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Ask AI

ai-corner-premiumai-corner-premium
ai-corner-premiumai-corner-premium

Frequently Asked Questions about Hemant Surgical Industries Ltd

Hemant Surgical Industries Ltd (HSIL) is currently trading at 260.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Hemant Surgical Industries Limited specializes in medical equipment and supplies, focusing on renal care, cardiovascular disease, and other critical care products. The company evolved from importing medical disposables to manufacturing a wide range of medical devices and solutions in India. Recent strategic partnerships with global entities like JMS Co. Ltd. and SWS Hemodialysis Care Co. Ltd. bolster its international reach. Distribution agreements expanding into markets such as the Philippines suggest aggressive global scaling and diversification. Hemant Surgical's public listing in May 2023 raised ₹25 crore, highlighting its growth ambitions.

Over the past 52 weeks, Hemant Surgical Industries Ltd has traded between a low of ₹88.15 and a high of ₹367.10. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Hemant Surgical Industries Ltd has a market capitalization of approximately 347.73. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Hemant Surgical Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 33.77 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 347.73 Cr, Hemant Surgical Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Hemant Surgical Industries Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Hemant Surgical Industries Ltd is 33.77. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.